Avaleht › Difuusne suure B-raku lümfoom › California › Los Angeles
Difuusne suure B-raku lümfoom kliinilised uuringud linnas Los Angeles, CA
17 uuringut haiguse Difuusne suure B-raku lümfoom jaoks otsivad osalejaid linnas Los Angeles ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
VärbamineFaas 2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
VärbamineFaas 2
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
VärbamineFaas 3
- Cedars-Sinai Medical Center ( Site 0115), Los Angeles
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
VärbamineFaas 3
- David Geffen School of Medicine at UCLA, Los Angeles
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
VärbamineFaas 1
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
VärbamineFaas 1/2
- Children's Hospital Los Angeles ( Site 1006), Los Angeles
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
VärbamineFaas 2
- Valkyrie Clinical Trials, Los Angeles
A Study of ARC-02 in B-cell NHL
VärbamineFaas 1
- Start Cala, Los Angeles
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
VärbamineFaas 1/2
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
VärbamineFaas 1
- Cedars-Sinai Medical Center, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
VärbamineFaas 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
VärbamineFaas 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles (UCLA), Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
VärbamineFaas 1
- START Los Angele, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
VärbamineFaas 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
VärbamineFaas 1/2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
VärbamineFaas 2
- Cedars Sinai Medical Center, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
VärbamineFaas 1
- University of Southern California, Los Angeles
Difuusne suure B-raku lümfoom uuringud teistes linnades
- New York City, NY21 uuringut
- Baldwin Park, CA19 uuringut
- Chicago, IL18 uuringut
- Houston, TX17 uuringut
- Boston, MA16 uuringut
- Milwaukee, WI16 uuringut
- Nashville, TN15 uuringut
- Portland, OR15 uuringut
- Philadelphia, PA15 uuringut
- Durham, NC14 uuringut
- Dallas, TX13 uuringut
- Seattle, WA12 uuringut
Muud uuringud linnas Los Angeles
- Mitteväikerakuline kopsuvähk87 uuringut
- Vähk (kõik liigid)73 uuringut
- Rinnavähk72 uuringut
- Eesnäärmevähk61 uuringut
- Käär- ja pärasoolevähk59 uuringut
- Metastaatiline vähk57 uuringut
- Munasarjavähk50 uuringut
- Kopsuvähk45 uuringut
- Pea ja kaela lameepiteeli kartsinoom42 uuringut
- Pankreasevähk35 uuringut
- Endomeetriumivähk34 uuringut
- Melanoom34 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.